Puma Biotechnology, Inc. (PBYI) Reports Q3 Loss of $1.29

Puma Biotechnology, Inc. (: PBYI) reported Q3 EPS of ($1.29), versus ($0.09) reported last year. Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Puma Biotechnology, Inc. (PBYI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Grandstand Limited (GRSD) Tops Q2 EPS by 5c; Offers Guidance
• Virtra Systems, Inc. (VTSI) Tops Q2 EPS by 9c
• Kyntra Bio, Inc. (KYNB) Tops Q2 EPS by 614c